Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.

Roberts RL, Wallace MC, Seinen ML, van Bodegraven AA, Krishnaprasad K, Jones GT, van Rij AM, Baird A, Lawrance IC, Prosser R, Bampton P, Grafton R, Simms LA, Studd C, Bell SJ, Kennedy MA, Halliwell J, Gearry RB, Radford-Smith G, Andrews JM, McHugh PC, Barclay ML.

Inflamm Bowel Dis. 2018 May 16. doi: 10.1093/ibd/izy163. [Epub ahead of print]

PMID:
29788244
2.

Development and evaluation of a risk assessment tool to improve clinical triage accuracy for colonoscopic investigations.

Lord AR, Simms LA, Brown A, Hanigan K, Krishnaprasad K, Schouten B, Croft AR, Appleyard MN, Radford-Smith GL.

BMC Cancer. 2018 Feb 27;18(1):229. doi: 10.1186/s12885-018-4140-0.

3.

Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method.

Chen GB, Lee SH, Montgomery GW, Wray NR, Visscher PM, Gearry RB, Lawrance IC, Andrews JM, Bampton P, Mahy G, Bell S, Walsh A, Connor S, Sparrow M, Bowdler LM, Simms LA, Krishnaprasad K; International IBD Genetics Consortium, Radford-Smith GL, Moser G.

BMC Med Genet. 2017 Aug 29;18(1):94. doi: 10.1186/s12881-017-0451-2.

4.

Guiding Principles for the use of Fluroquinolones in Out-patient Community Settings of India: Panel Consensus.

Vora A, Krishnaprasad K.

J Assoc Physicians India. 2017 Aug;65(8):51-52.

PMID:
28799307
5.

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.

Doecke JD, Hartnell F, Bampton P, Bell S, Mahy G, Grover Z, Lewindon P, Jones LV, Sewell K, Krishnaprasad K, Prosser R, Marr D, Fischer J, R Thomas G, Tehan JV, Ding NS, Cooke SE, Moss K, Sechi A, De Cruz P, Grafton R, Connor SJ, Lawrance IC, Gearry RB, Andrews JM, Radford-Smith GL; Australian and New Zealand Inflammatory Bowel Disease Consortium.

Aliment Pharmacol Ther. 2017 Feb;45(4):542-552. doi: 10.1111/apt.13880. Epub 2016 Dec 19.

PMID:
27995633
6.

Exploring the hidden potential of fosfomycin for the fight against severe Gram-negative infections.

Saiprasad PV, Krishnaprasad K.

Indian J Med Microbiol. 2016 Oct-Dec;34(4):416-420. doi: 10.4103/0255-0857.195379. Review.

7.

A Method to Exploit the Structure of Genetic Ancestry Space to Enhance Case-Control Studies.

Bodea CA, Neale BM, Ripke S; International IBD Genetics Consortium, Daly MJ, Devlin B, Roeder K.

Am J Hum Genet. 2016 May 5;98(5):857-868. doi: 10.1016/j.ajhg.2016.02.025. Epub 2016 Apr 14.

8.

Natural Micronized Progesterone Sustained Release (SR) and Luteal Phase: Role Redefined!!

Malik S, Krishnaprasad K.

J Clin Diagn Res. 2016 Feb;10(2):QE01-4. doi: 10.7860/JCDR/2016/17278.7212. Epub 2016 Feb 1. Review.

9.
10.

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T, Andersen V, Andrews JM, Annese V, Brand S, Brant SR, Cho JH, Daly MJ, Dubinsky M, Duerr RH, Ferguson LR, Franke A, Gearry RB, Goyette P, Hakonarson H, Halfvarson J, Hov JR, Huang H, Kennedy NA, Kupcinskas L, Lawrance IC, Lee JC, Satsangi J, Schreiber S, Théâtre E, van der Meulen-de Jong AE, Weersma RK, Wilson DC; International Inflammatory Bowel Disease Genetics Consortium, Parkes M, Vermeire S, Rioux JD, Mansfield J, Silverberg MS, Radford-Smith G, McGovern DP, Barrett JC, Lees CW.

Lancet. 2016 Jan 9;387(10014):156-67. doi: 10.1016/S0140-6736(15)00465-1. Epub 2015 Oct 18.

11.

Necrotizing Fasciitis of Hand By Methicillin Resistant Staphylococcus aureus (MRSA) - A Sinister.

Chauhan H, Patil S, Hajare A, Krishnaprasad K, Bhargava A.

J Clin Diagn Res. 2015 Jun;9(6):DD01-2. doi: 10.7860/JCDR/2015/12381.6014. Epub 2015 Jun 1.

12.

A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India.

Hajare A, Gupta A, Patil S, Krishnaprasad K, Bhargava A.

Int J Appl Basic Med Res. 2015 May-Aug;5(2):87-91. doi: 10.4103/2229-516X.157151.

13.

In Vitro Fractional Inhibitory Concentration (FIC) Study of Cefixime and Azithromycin Fixed Dose Combination (FDC) Against Respiratory Clinical Isolates.

Patil SV, Hajare AL, Patankar M, Krishnaprasad K.

J Clin Diagn Res. 2015 Feb;9(2):DC13-5. doi: 10.7860/JCDR/2015/12092.5560. Epub 2015 Feb 1.

14.

Garenoxacin in Skin and Skin Structure Infections Sustained due to Road Traffic Accident.

Pukar MM, Hajare AL, Krishnaprasad K, Bhargava AI.

J Clin Diagn Res. 2014 Jun;8(6):HD01-3. doi: 10.7860/JCDR/2014/9066.4458. Epub 2014 Jun 20.

15.

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

Roberts RL, Wallace MC, Seinen ML, Krishnaprasad K, Chew A, Lawrance I, Prosser R, Bampton P, Grafton R, Simms L, Studd C, Bell SJ, Radford-Smith G, Andrews JM, Barclay ML.

Am J Gastroenterol. 2014 Jun;109(6):925-7. doi: 10.1038/ajg.2014.89. No abstract available. Erratum in: Am J Gastroenterol. 2015 Jan;110(1):204. Studd, Corrie [added]; Bell, Sally J [added].

PMID:
24896764
16.

Crohn's disease and smoking: is it ever too late to quit?

Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K, Andrews JM, Prosser R, Bampton PA, Cooke SE, Mahy G, Radford-Smith G, Croft A, Hanigan K.

J Crohns Colitis. 2013 Dec;7(12):e665-71. doi: 10.1016/j.crohns.2013.05.007. Epub 2013 Jun 20.

PMID:
23790611
17.

Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease.

Doecke JD, Simms LA, Zhao ZZ, Huang N, Hanigan K, Krishnaprasad K, Roberts RL, Andrews JM, Mahy G, Bampton P, Lewindon P, Florin T, Lawrance IC, Gearry RB, Montgomery GW, Radford-Smith GL.

Inflamm Bowel Dis. 2013 Feb;19(2):240-5. doi: 10.1097/MIB.0b013e3182810041.

PMID:
23348120
18.

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH.

Nature. 2012 Nov 1;491(7422):119-24. doi: 10.1038/nature11582.

20.

Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study.

Krishnaprasad K, Andrews JM, Lawrance IC, Florin T, Gearry RB, Leong RW, Mahy G, Bampton P, Prosser R, Leach P, Chitti L, Cock C, Grafton R, Croft AR, Cooke S, Doecke JD, Radford-Smith GL.

J Crohns Colitis. 2012 Apr;6(3):287-93. doi: 10.1016/j.crohns.2011.08.016. Epub 2011 Oct 4.

PMID:
22405164

Supplemental Content

Loading ...
Support Center